RecruitingPhase 2Phase 3ACTRN12610000322033

The role of vitamin D in the treatment of nerve pain in diabetes

Vitamin D as an analgesic for neuropathic pain in type 2 diabetes


Sponsor

St Vincent's Hospital

Enrollment

60 participants

Start Date

Apr 1, 2010

Study Type

Interventional

Conditions

Summary

Vitamin D deficiency is common amongst people with type 2 diabetes. People with type 2 diabetes frequently develop painful neuropathy ("nerve pain" especially in the feet). The study hypothesis is that vitamin D supplementation may improve symptoms of nerve pain. The study is therefore designed to investigate the impact of vitamin D supplementation on nerve pain in people with type 2 diabetes


Eligibility

Sex: Both males and femalesMin Age: 40 YearssMax Age: 80 Yearss

Inclusion Criteria1

  • Patients with type 2 diabetes and with painful neuropathy with a serum 25-hydroxyvitamin D level of less than 50 nmol/L

Exclusion Criteria1

  • Patients with type 1 or secondary diabetes, hypercalcaemia or renal stone

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Intramuscular vitamin D injection (300,000 units) at baseline

Intramuscular vitamin D injection (300,000 units) at baseline


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610000322033